Taltz ® (ixekizumab)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Taltz Summary of Product Characteristics (SmPC)

Taltz® (Ixekizumab): New Packaging

Changes to the designs of Ixekizumab cartons, labels and leaflets occurred in August 2020. The devices and the manufacturing process have not changed.

Further information

The major changes are as follow:1

Carton:

  • The pre-filled pen and pre-filled syringe cartons have been redesigned and are slightly longer and wider

  • The cartons close differently

  • The location/placement of graphics and printing has been changed slightly

  • The green backgrounds on the end flap were removed

Label:

  • The Lilly logo design on the pre-filled pen and pre-filled syringe labels has been changed

  • The location of the batch number and expiration date information has been moved from right to left on the label of the pre-filled pen

Instructions for Use:

  • The picture showing the location of the batch number and expiration date information on the pre-filled pen label has been moved from right to left

References

1. Data on file, Eli Lilly and Company and/or one of its subsidiaries.

Date of Last Review: November 19, 2020


Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 10am - 4pm, excluding Bank Holidays

Or you can

Chat with Us

Click to Chat is Offline

If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a request